ACADIA Pharmaceuticals, Inc. (ACAD)
21.27
+0.01
(+0.05%)
USD |
NASDAQ |
May 27, 12:18
ACADIA Pharmaceuticals Market Cap : 3.642B for May 27, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Insmed, Inc. | 23.19B |
| Madrigal Pharmaceuticals, Inc. | 12.11B |
| Regeneron Pharmaceuticals, Inc. | 65.82B |
| ADMA Biologics, Inc. | 1.867B |
| Arcutis Biotherapeutics, Inc. | 2.716B |
Market Cap Related Metrics
| PE Ratio | 9.684 |
| PS Ratio | 3.318 |
| PEG Ratio | 0.1617 |
| Price to Book Value | 2.918 |
| Price to Free Cash Flow | 31.99 |
| Price | 21.27 |
| Earnings Yield | 10.33% |
| PEGY Ratio | 0.1617 |
| Operating PE Ratio | 44.92 |
| Normalized PE Ratio | 9.685 |